Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2026-06-04 @ 11:58 PM
Study NCT ID:
NCT05687032
Status:
COMPLETED
Last Update Posted:
2025-12-03
First Post:
2023-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor:
Pfizer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
B1931034
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None